BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 6113999)

  • 1. Determination of bioavailability on the basis of tachycardia after intravenous and oral administration of fenoterol, orciprenaline and salbutamol in non-anaesthetized rats.
    Muacevic G
    Arzneimittelforschung; 1985; 35(1A):406-8. PubMed ID: 2859035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different mechanisms of action of beta2-adrenergic receptor agonists: a comparison of reproterol, fenoterol and salbutamol on monocyte cyclic-AMP and leukotriene B4 production in vitro.
    Juergens UR; Stöber M; Libertus H; Darlath W; Gillissen A; Vetter H
    Eur J Med Res; 2004 Jul; 9(7):365-70. PubMed ID: 15337638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tonometric, kymographic and radiological studies of the effect of some drugs on uterotubal contractility].
    Marzetti L; Agostini R; Zichella L; Pachì A; Carenza L
    Patol Clin Ostet Ginecol; 1975; 1(6):248-54. PubMed ID: 172390
    [No Abstract]   [Full Text] [Related]  

  • 4. [Uterine activity under tocolysis through a beta-sympathomimetic (author's transl)].
    Warkentin B
    Z Geburtshilfe Perinatol; 1976 Jun; 180(3):230-3. PubMed ID: 8884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inhibition of menstrual uterine motility with four beta-adrenergic drugs (author's transl)].
    Cifuentes R; Cobo E
    Reproduccion; 1981; 5(1):31-41. PubMed ID: 6113999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic/pharmacodynamic characteristics of the beta-2-agonists terbutaline, salbutamol and fenoterol.
    Hochhaus G; Möllmann H
    Int J Clin Pharmacol Ther Toxicol; 1992 Sep; 30(9):342-62. PubMed ID: 1358833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapy of preterm labor.
    Souney PF; Kaul AF; Osathanondh R
    Clin Pharm; 1983; 2(1):29-44. PubMed ID: 6136361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antispasmodic agents (author's transl)].
    Colasson F; Kamina P; Courtois P; de Tourris H
    J Gynecol Obstet Biol Reprod (Paris); 1980; 9(3):377-88. PubMed ID: 6109743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the beta3-adrenoceptor (ADRB3) a potential target for uterorelaxant drugs?
    Bardou M; Rouget C; Breuiller-Fouché M; Loustalot C; Naline E; Sagot P; Frydman R; Morcillo EJ; Advenier C; Leroy MJ; Morrison JJ
    BMC Pregnancy Childbirth; 2007 Jun; 7 Suppl 1(Suppl 1):S14. PubMed ID: 17570158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drugs inhibiting contractions].
    Bergsjo P
    Tidsskr Nor Laegeforen; 1973 Nov; 93(31):2327-30. PubMed ID: 4149170
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of beta-adrenoceptor agonists on electrical and mechanical activity of the myometrium.
    Andersson KE; Bengtsson B
    Acta Pharmacol Toxicol (Copenh); 1979; 44 Suppl 2():64-75. PubMed ID: 41401
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.